Is Cancer a Risk for RA Patients?

JULY 01, 2003

Swedish researchers conducted a study to determine whether the increased risk of malignant lymphomas in patients with rheumatoid arthritis (RA) was the result of environmental and genetic factors rather than a consequence of the disease itself. For their study, the researchers looked at 76,527 patients hospitalized with RA between 1964 and 1999. The participants were followed for >3 decades, and any occurrences of cancer were reported. In addition, to rule out genetic factors, the scientists looked at the incidence of malignant lymphomas in the first-degree relatives of the patients.

The results showed a significant increase in the risk of malignant lymphomas in RA patients.

The investigators concluded that lymphomas complicating RA appear to be a direct consequence of the inflammation or its treatment. There was no increase in the risk of cancer among first-degree relatives with RA.


Become a Respimat Top Performer 

Get to know RESPIMAT, the slow-moving mist inhaler from Boehringer Ingelheim Pharmaceuticals, Inc. 

Watch the RESPIMAT video and test your knowledge with a short multiple-choice quiz. When you get all the answers right, you’ll receive a certificate naming you a RESPIMAT T.O.P. Performer. Why not check it out today? 


Pharmacy Times Strategic Alliance

Pharmacist Education
Clinical features with downloadable PDFs

Next-Generation Pharmacist® Awards

3rd Annual Convenient Healthcare and Pharmacy Collaborative Conference

Personalize the information you receive by selecting targeted content and special offers.